QUIT
Achieve Life SciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
$6.40-$0.38 (-5.60%)
At close · 2026-11-10
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
QUIT vs peer average
48/100
QUIT vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $658.24M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
QUIT
Achieve Life Sciences
ACRS
Aclaris Therapeutics
Grade
D
D
Momentum
47
14
Value
41
41
Sentiment
-
70
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ACRS
QUIT / ACRS
Grade Position
In line
QUIT vs. peer average (D vs. D)
48/100
Momentum
47
QUITValue
41
QUITSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs QUIT
ACRS is the first peer returned for this comparison set.